BioStem Technologies, Inc.
Biotechnology · POMPANO BEACH, FL
BiotechnologySEC Form D
BioStem Technologies, Inc. filed a Form D with the U.S. Securities and Exchange Commission on June 3, 2026, reporting $2,500,000 raised.
Incorporated in Florida and based in POMPANO BEACH, FL, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that BioStem Technologies, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Jason MatuszewskiExecutive Officer · Director
- Brandon PoeExecutive Officer
- Andrew Van VurstExecutive Officer · Director
- Barry HassettExecutive Officer
- Katherine GorrellExecutive Officer
- Kenneth WarringtonDirector
- Thomas J. DuganDirector
- Patrick DalyDirector
- Jodi UngrodtDirector
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$10.0MRaised
Senti Biosciences Holdings, Inc.
$1.6MRaised